ACTIV in CHF: Difference between revisions

Latest revision as of 20:19, 20 August 2013

Redirect to:

Revision as of 23:15, 26 June 2009 (view source) Michaelagibson (talk \| contribs) (←Redirected page to Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure)		Latest revision as of 20:19, 20 August 2013 (view source) Vendhan Ramanujam (talk \| contribs) No edit summary
Line 1:		Line 1:
	#redirect:[[Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure]]		#redirect:[[Acute And Chronic Therapeutic Impact Of A Vasopressin 2 Antagonist (Tolvaptan) In Congestive Heart Failure]]

			[[Category:Clinical trials]]